83 related articles for article (PubMed ID: 9639723)
1. [Vaginal template implant for cervical carcinoma with vaginal stenosis].
Damon C
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):399-401. PubMed ID: 9639723
[TBL] [Abstract][Full Text] [Related]
2. Vaginal template implant for cervical carcinoma with vaginal stenosis or inadvertent diagnosis after hysterectomy.
Choy D; Wong RL; Sham J; Wu PM; Foo DL; Ngan HY; Ma HK
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):457-62. PubMed ID: 8276661
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma.
Weitmann HD; Knocke TH; Waldhäusl C; Pötter R
Strahlenther Onkol; 2006 Feb; 182(2):86-95. PubMed ID: 16447015
[TBL] [Abstract][Full Text] [Related]
4. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
Agrawal PP; Singhal SS; Neema JP; Suryanarayan UK; Vyas RK; Rathi AK; Bahadur AK
Gynecol Oncol; 2005 Oct; 99(1):169-75. PubMed ID: 16081150
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
6. High-dose-rate interstitial brachytherapy in the management of carcinoma of the uterine cervix and other gynecologic malignancies.
Sitathanee C; Pairatchvet V; Narkwong L; Puataweepong P
J Med Assoc Thai; 2005 Aug; 88(8):1045-50. PubMed ID: 16404830
[TBL] [Abstract][Full Text] [Related]
7. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
8. Accurate and economical intracavitary endocurietherapy in the treatment of uterine cervix cancer.
Kumar PP; Good RR
Strahlenther Onkol; 1986 Jan; 162(1):8-12. PubMed ID: 3945922
[TBL] [Abstract][Full Text] [Related]
9. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
[TBL] [Abstract][Full Text] [Related]
10. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
12. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of high-dose-rate brachytherapy of the preoperative treatment of stage IB (FIGO) cervical carcinoma].
Mayer A; Nemeskéri C; Póti Z
Magy Onkol; 2004; 48(2):141-4. PubMed ID: 15351809
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
16. Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer.
Yoshida K; Yamazaki H; Nakamura S; Masui K; Kotsuma T; Akiyama H; Tanaka E; Yoshikawa N; Uesugi Y; Shimbo T; Narumi Y; Yoshioka Y
J Gynecol Oncol; 2015 Jul; 26(3):179-84. PubMed ID: 25925294
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
18. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
Khor TH; Tuan JK; Hee SW; Tham IW
Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
[TBL] [Abstract][Full Text] [Related]
19. A new technique for performing Syed template interstitial implants for anterior vaginal tumors using an open retropubic approach.
Paley PJ; Koh WJ; Stelzer KJ; Goff BA; Tamimi HK; Greer BE
Gynecol Oncol; 1999 Apr; 73(1):121-5. PubMed ID: 10094892
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
